David J Dabbs Selected Research

2,4,5-trimethoxyphenylisopropylamine (TMA-2)

11/2009	PAX 2: a novel Müllerian marker for serous papillary carcinomas to differentiate from micropapillary breast carcinoma.
11/2008	CK5 is more sensitive than CK5/6 in identifying the "basal-like" phenotype of breast carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David J Dabbs Research Topics

Disease

54	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2002
44	Neoplasms (Cancer) 01/2021 - 02/2002
17	Carcinoma (Carcinomatosis) 01/2022 - 02/2002
10	Lobular Carcinoma 01/2022 - 01/2007
7	Noninfiltrating Intraductal Carcinoma (DCIS) 06/2018 - 03/2006
6	Pathologic Complete Response 01/2021 - 01/2009
5	Ductal Carcinoma 01/2022 - 09/2007
3	Adenocarcinoma 02/2013 - 02/2002
2	Papillary Carcinoma 11/2009 - 02/2009
1	Wilms Tumor (Wilm's Tumor) 01/2017
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017
1	Melanoma (Melanoma, Malignant) 07/2014
1	Confusion (Bewilderment) 07/2013
1	Sweat Gland Neoplasms 08/2011
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 06/2010
1	Necrosis 02/2010
1	Papilloma (Papillomatosis) 02/2009
1	Neoplasm Micrometastasis 02/2009
1	Endometrial Neoplasms (Endometrial Cancer) 07/2008
1	Giant Cell Arteritis (Horton Disease) 07/2007
1	Ovarian Cysts (Ovarian Cyst) 07/2007
1	Lymphatic Metastasis 01/2007
1	Hyperplasia 03/2006
1	Neoplasm Metastasis (Metastasis) 03/2004
1	Adenocarcinoma of Lung 02/2002

Drug/Important Bio-Agent (IBA)

27	Estrogen ReceptorsIBA 01/2021 - 02/2002
20	Progesterone Receptors (Progesterone Receptor)IBA 01/2021 - 02/2002
11	Hormones (Hormone)IBA 01/2021 - 07/2008
10	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2007
9	Biomarkers (Surrogate Marker)IBA 01/2021 - 12/2008
7	Cadherins (E-Cadherin)IBA 07/2013 - 01/2007
6	Keratins (Keratin)IBA 01/2022 - 03/2004
6	Estrogens (Estrogen)FDA Link 03/2014 - 01/2007
6	Phenobarbital (Luminal)FDA Link 05/2011 - 01/2008
5	AntibodiesIBA 03/2015 - 01/2007
4	human ERBB2 proteinIBA 01/2021 - 05/2011
4	Androgen Receptors (Androgen Receptor)IBA 01/2017 - 02/2010
4	CateninsIBA 07/2013 - 01/2007
3	Biological ProductsIBA 06/2018 - 12/2009
3	VimentinIBA 01/2017 - 11/2006
3	Trastuzumab (Herceptin)FDA Link 10/2013 - 02/2010
2	ParaffinIBA 01/2019 - 03/2006
2	ErbB Receptors (EGF Receptor)IBA 07/2012 - 03/2010
2	Formaldehyde (Formol)FDA Link 05/2012 - 03/2006
2	2,4,5-trimethoxyphenylisopropylamine (TMA-2)IBA 11/2009 - 11/2008
2	Monoclonal AntibodiesIBA 03/2007 - 02/2002
1	somatotropin releasing hormone receptorIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2020
1	Tumor Biomarkers (Tumor Markers)IBA 01/2019
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2019
1	formic acid (formate)IBA 01/2019
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2017
1	Keratin-20 (Cytokeratin 20)IBA 01/2017
1	Keratin-7 (Cytokeratin 7)IBA 01/2017
1	Carrier Proteins (Binding Protein)IBA 01/2017
1	Thyroid Nuclear Factor 1IBA 01/2017
1	Uroplakin IIIBA 01/2017
1	RNA (Ribonucleic Acid)IBA 11/2016
1	Tamoxifen FDA LinkGeneric 03/2014
1	DNA ProbesIBA 01/2014
1	Carcinoembryonic AntigenIBA 02/2013
1	LigandsIBA 05/2011
1	Insulin-Like PeptidesIBA 05/2011
1	Somatomedin Receptors (Somatomedin Receptor)IBA 05/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 05/2011
1	Inhibins (Inhibin)IBA 07/2010
1	SteroidsIBA 07/2010
1	MART-1 AntigenIBA 07/2010
1	Calbindin 2IBA 07/2010
1	MucinsIBA 06/2010
1	Green Fluorescent ProteinsIBA 06/2010
1	Progesterone FDA LinkGeneric 02/2010
1	AndrogensIBA 02/2010
1	Transcription Factors (Transcription Factor)IBA 11/2009
1	Collagen Type IV (Type IV Collagen)IBA 02/2009
1	erucylphosphocholineIBA 02/2009
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2008
1	UteroglobinIBA 07/2008
1	Oncogene Proteins (Oncogene Protein)IBA 04/2008
1	Delta CateninIBA 03/2007
1	beta CateninIBA 01/2007
1	Combined Antibody TherapeuticsIBA 01/2007
1	alpha Catenin (alpha E-Catenin)IBA 01/2007
1	gamma Catenin (Plakoglobin)IBA 01/2007
1	Endothelin-1 (Endothelin 1)IBA 10/2006
1	Coloring Agents (Dyes)IBA 03/2004
1	EpitopesIBA 02/2002

Therapy/Procedure

14	Therapeutics 01/2021 - 12/2008
12	Neoadjuvant Therapy 01/2021 - 01/2009
7	Drug Therapy (Chemotherapy) 10/2018 - 02/2010
2	Segmental Mastectomy (Lumpectomy) 07/2014 - 10/2013
1	Radiotherapy 07/2014
1	Mastectomy (Mammectomy) 03/2013
1	Quantum Dots (Quantum Dot) 03/2013
1	Curettage 02/2013
1	Complementary Therapies (Alternative Medicine) 02/2010
1	Aftercare (After-Treatment) 12/2008
1	Salpingo-oophorectomy 07/2007
1	Lymph Node Excision (Lymph Node Dissection) 10/2004